|Min SIP Amount||₹1000|
|NAV||₹81.20 (25 Jan 2021)|
|Fund Started||07 Jan 2013|
|Fund Size||₹26 Cr|
|Fortis Healthcare (India) Ltd||Healthcare||Equity||8.8%|
|Godrej Agrovet Ltd.||FMCG||Equity||8.0%|
|Aarti Industries Ltd.||Chemicals||Equity||7.9%|
|Alembic Pharmaceuticals Ltd.||Healthcare||Equity||7.9%|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||7.5%|
|Stylam Industries Ltd.||FMCG||Equity||6.8%|
|Adani Enterprises Ltd.||Services||Equity||6.5%|
|PI Industries Ltd.||Chemicals||Equity||5.4%|
|Hindustan Aeronautics Ltd.||Services||Equity||4.8%|
Quant Mid Cap Fund Direct Growth is a Equity Mutual Fund Scheme launched by Quant Mutual Fund. This scheme was made available to investors on 07 Jan 2013. Sanjeev Sharma is the Current Fund Manager of Quant Mid Cap Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹26 Cr and the Latest NAV as of 25 Jan 2021 is ₹81.20.
The Quant Mid Cap Fund Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 1000. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 1 year
The scheme aims at providing long term capital appreciation and generating income with a diversified portfolio of Mid Cap companies.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.